TSHA

Taysha Gene Therapies, Inc.

3.10 USD
+0.01 (+0.32%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Taysha Gene Therapies, Inc. stock is up 36.56% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 May’s closed higher than April. In the last 1 Unusual Options Trades, there were 1 CALL. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
21 Mar 18:02 19 Jul, 2024 2.00 CALL 500 876

About Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc. focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company was incorporated in 2019 and is based in Dallas, Texas.

  • Jefferies
    Tue May 14, 08:18
    buy
    initial
  • Needham
    Thu May 2, 13:18
    buy
    confirm
  • Cantor Fitzgerald
    Tue Apr 30, 10:26
    buy
    confirm